Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Infocom And KNIME GmbH Jointly Develop Modules for Drug Development Technology

This article was originally published in PharmAsia News

Executive Summary

Tokyo-based Infocom Corp, a system developer for pharmaceutical research facilities, has signed a licensing agreement with the German firm KNIME GmbH for developing and marketing business computer processing modules based on KNIME, a work flow platform designed to assist drug development research. KNIME, developed by Konstanz University in Germany, is an open system platform which is customizable for different modules and systems. Additionally, Infocom's licensing agreements with Hungarian company ChemAxon and KNIME have allowed it to develop the cheminformatics program suite JChem Node Extension, expected to launch in February 2008. (Click here for more-Japanese language

Latest Headlines
See All
UsernamePublicRestriction

Register

SC066700

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel